Latest News About - Antiviral

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Sunday, October 21, 2018

9:27:00 PM CEST

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Most reported countries (24h)

Theme countries

AlertLevel (24h)

Alert level graph

 Previous 14 days average

Alert level:
 high   medium   low

Quotes... Extracted quotes

Ruth Itzhaki said: "Our theory is that in APOE-ε4 carriers, reactivation is more frequent or more harmful in HSV1-infected brain cells, which as a result accumulate damage that culminates in development of Alzheimer's" External link

telegraph Friday, October 19, 2018 4:06:00 PM CEST

Ruth Itzhaki said: "The striking results include evidence that the risk of senile dementia is much greater in those who are infected with HSV, and that anti-herpes antiviral treatment causes a dramatic decrease in number of those subjects severely affected by HSV1 who later develop dementia" External link

telegraph Friday, October 19, 2018 4:06:00 PM CEST

Emmanuel Caeymaex said: "The studies presented this week at ACR/ARHP 2018 represent the potential for CIMZIA to treat multiple patient populations and further demonstrate our commitment to providing optimal disease management solutions, particularly for patients living with psoriatic arthritis and conditions across the entire axSpA disease spectrum. We are also presenting research that contributes to improved understanding of the treatment needs for women of childbearing age with chronic inflammatory disease," External link

markets-businessinsider Friday, October 19, 2018 1:37:00 PM CEST

Ruth Itzhaki said: “Viral DNA is located very specifically within plaques in postmortem brain tissue from Alzheimer's sufferers,” “The main proteins of both plaques and tangles accumulate also in HSV1-infected cell cultures—and antiviral drugs can prevent this,” External link

newsweek-USA Friday, October 19, 2018 12:31:00 PM CEST

Ruth Itzhaki says: “HSV1 could account for 50% or more of Alzheimer’s disease cases,” External link

outbreaknewstoday Friday, October 19, 2018 11:54:00 AM CEST

Ruth Itzhaki admits: “It should be stressed that the results of these Taiwanese studies apply only to severe HSV1 (or VZV) infections, which are rare,” “Ideally, we would study dementia rates amongst people who have suffered mild HSV1 infection, including herpes labialis (cold sores) or mild genital herpes, but these are far less likely to be documented” External link

outbreaknewstoday Friday, October 19, 2018 11:54:00 AM CEST

Ruth Itzhaki added: “Our theory is that in APOE-4 carriers, reactivation is more frequent or more harmful in HSV1-infected brain cells, which as a result accumulate damage that culminates in development of Alzheimer’s,” External link

southwalesargus Friday, October 19, 2018 11:19:00 AM CEST

James Pickett added: “Herpes is a hot topic in dementia research, as the infection appears to be more common in the brains of people with Alzheimer’s compared to healthy brains but we don’t yet know enough about the relationship between the two,” External link

southwalesargus Friday, October 19, 2018 11:19:00 AM CEST

Ian McGowan commented: "This collaboration brings together Gilead's extensive experience in antiviral drug development with our highly innovative vaccine platform" External link

finanznachrichten-en Thursday, October 18, 2018 10:15:00 AM CEST

John McHutchison said: "Gilead is committed to the research and development of new therapies that may help inform potential cure strategies for people living with HIV," External link

finanznachrichten-en Thursday, October 18, 2018 10:15:00 AM CEST

Andreas Michalsen sagt: "Wunder darf man von alldem aber nicht erwarten" "All diese Dinge lindern etwas die Beschwerden, sie sorgen aber nicht dafür, dass man sofort wieder fit ist" External link

wr Thursday, October 4, 2018 2:49:00 PM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.